Pricing Log in Create free account

Abivax SA Sponsored ADR (ABVX) vs Spyre Therapeutics, Inc. (SYRE)

Abivax SA Sponsored ADR and Spyre Therapeutics, Inc. are both Biotechnology companies. Spyre Therapeutics, Inc. is the larger, with a market value of $9.2B against $7.4B — 1.2× the size. Across the 10 metrics below, Spyre Therapeutics, Inc. leads on 9 and Abivax SA Sponsored ADR on 1.

Valuation

Metric ABVX SYRE Biotechnology median
P/E n/m n/m 10.26
P/S n/m 8,159.98 9.18
P/B 15.83 9.50 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m 7,142.99 8.98
Earnings yield (7.16%) (3.16%) (34.89%)
Free cash flow yield (3.35%) (2.89%) (24.52%)

Profitability

Metric ABVX SYRE Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (249.78%) (41.15%) (50.12%)
Return on assets (137.67%) (30.89%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABVX SYRE Biotechnology median
Revenue growth (TTM) — (81.84%) 6.26%
EPS growth (last fiscal year) (80.20%) 55.24% 29.88%
Revenue growth, 5-year CAGR — (28.15%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABVX SYRE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.97 27.40 4.89
Net debt to EBITDA 2.19 3.61 1.01

Dividend

Metric ABVX SYRE Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABVX SYRE Biotechnology median
Market cap 7.37b 9.17b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack